Denmark‘s economy is heading for slower growth as the pharmaceutical boom led by Novo Nordisk A/S loses steam and the industry settles into a pace more in line with the rest of the economy, the country’s financial watchdog said.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.